Non-Alcoholic Fatty Liver Disease (NAFLD): The Search for a Cure

Alabagi Abdulla, Charity Reynolds, *H Hesham A-Kader

Division of Gastroenterology, Hepatology and Nutrition, Department of Pediatrics, University of Arizona, Tucson, Arizona, USA
*Correspondence to heshamh@aol.com

Disclosure: The authors have declared no conflicts of interest.
Received: 23.11.15 Accepted: 18.02.16
Citation: EMJ. 2016;1[2]:93-100.

Abstract

An alarming rise of obesity and, along with it, non-alcoholic fatty liver disease (NAFLD), has been observed in the USA and the rest of the world. NAFLD, the most common cause of chronic liver disease in many developed countries, is not always a benign disorder and considering its growing nature, will have a serious impact on healthcare systems worldwide. The search continues for a suitable therapy for this disorder; the therapy ideally needs to be safe, effective, and affordable. The biggest hurdle in the process of developing such a therapy is our lack of a complete understanding of the pathogenesis of the disease.

Download (PDF, 128KB)

Comments are closed.